KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelon (EXC) Asset Writedowns and Impairment (2016 - 2022)

Historic Asset Writedowns and Impairment for Exelon (EXC) over the last 12 years, with Q4 2022 value amounting to $2.0 million.

  • Exelon's Asset Writedowns and Impairment fell 8181.82% to $2.0 million in Q4 2022 from the same period last year, while for Dec 2023 it was $48.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $48.0 million for FY2022, which is 9130.43% down from last year.
  • Latest data reveals that Exelon reported Asset Writedowns and Impairment of $2.0 million as of Q4 2022, which was down 8181.82% from $46.0 million recorded in Q3 2022.
  • Over the past 5 years, Exelon's Asset Writedowns and Impairment peaked at $534.0 million during Q3 2020, and registered a low of $1.0 million during Q4 2018.
  • Over the past 5 years, Exelon's median Asset Writedowns and Impairment value was $24.0 million (recorded in 2020), while the average stood at $84.8 million.
  • Per our database at Business Quant, Exelon's Asset Writedowns and Impairment crashed by 9882.35% in 2018 and then soared by 260000.0% in 2019.
  • Over the past 5 years, Exelon's Asset Writedowns and Impairment (Quarter) stood at $1.0 million in 2018, then soared by 2600.0% to $27.0 million in 2019, then dropped by 11.11% to $24.0 million in 2020, then tumbled by 54.17% to $11.0 million in 2021, then crashed by 81.82% to $2.0 million in 2022.
  • Its Asset Writedowns and Impairment stands at $2.0 million for Q4 2022, versus $46.0 million for Q3 2022 and $11.0 million for Q4 2021.